↓ Skip to main content

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Overview of attention for article published in Annals of the Rheumatic Diseases, March 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
10 news outlets
blogs
1 blog
twitter
87 X users

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Published in
Annals of the Rheumatic Diseases, March 2024
DOI 10.1136/ard-2024-225531
Pubmed ID
Authors

Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, Annamaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Philip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Georg Schett, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée van der Heijde, Josef S Smolen

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 87 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 112 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 30 27%
Student > Ph. D. Student 10 9%
Other 8 7%
Lecturer 6 5%
Student > Master 5 4%
Other 13 12%
Unknown 40 36%
Readers by discipline Count As %
Unspecified 30 27%
Medicine and Dentistry 25 22%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Immunology and Microbiology 4 4%
Agricultural and Biological Sciences 3 3%
Other 2 2%
Unknown 44 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 128. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2024.
All research outputs
#349,043
of 26,579,895 outputs
Outputs from Annals of the Rheumatic Diseases
#128
of 7,930 outputs
Outputs of similar age
#5,696
of 356,100 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#2
of 54 outputs
Altmetric has tracked 26,579,895 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,930 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,100 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.